Effect and Safety of Mycophenolate Mofetil or Sodium in Systemic Sclerosis-Associated Interstitial Lung Disease: A Meta-Analysis

Background. Interstitial lung disease (ILD) is the most common complication of systemic sclerosis (SSc) with treatment ineffective. Objective: The aim of this meta-analysis was to provide an estimate of the safety and efficacy profile of Mycophenolate Mofetil (MMF) or sodium (MMS) in SSc-ILD patient...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Tzouvelekis, Argyris, Galanopoulos, Nikolaos, Bouros, Evangelos, Kolios, George, Zacharis, George, Ntolios, Paschalis, Koulelidis, Andreas, Oikonomou, Anastasia, Bouros, Demosthenes
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2012
Teme:
Clinical Study
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3357562/
https://ncbi.nlm.nih.gov/pubmed/22655194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/143637
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items